Pre-Clinical Development of BCG.HIVACAT, an Antibiotic-Free Selection Strain, for HIV-TB Pediatric Vaccine Vectored by Lysine Auxotroph of BCG

Overview of attention for article published in PLOS ONE, August 2012

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 14 Dimensions

Readers on

mendeley: 67 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 14 publications that cite this research output.

14

The most recent citing publications are shown below. View all 14 publications that cite this research output on Dimensions.

Auxotrophic Mycobacterium bovis BCG: Updates and Perspectives

Article in Vaccines (May 2022)

Анализ и перспективы применения рекомбинантного вируса вакцины, штамм MVA, в качестве вектора при разработке вакцин против заболеваний, вызванных вирусами иммунодефицита человека и обезьян

Article in Problems of Particularly Dangerous Infections (July 2019)

Priming With Recombinant BCG Expressing Novel HIV-1 Conserved Mosaic Immunogens and Boosting With Recombinant ChAdOx1 Is Safe, Stable, and Elicits HIV-1-Specific T-Cell Responses in BALB/c Mice

Article in Frontiers in Immunology (May 2019)